YTHDF2 and acute myeloid leukemia: discovered that YTHDF2 inhibits TNF‐α expression through an m6A‐mediated mRNA decay mechanism, thereby suppressing apoptosis and promoting LSC self‐renewal as well as AML initiation and progression.